Ganz, Tomas
University of California, Los Angeles
87 papers on CoChatORCID 0000-0002-2830-5469
Most cited papers
- Verified
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 4,803
- Verified
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology
Antimicrobial Peptides and ActivitiesInvertebrate Immune Response Mechanisms
Cited by 3,066
- Verified
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 2,650
- Verified
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry
Antimicrobial Peptides and ActivitiesIron Metabolism and Disorders
Cited by 2,168
- Verified
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine
Antimicrobial Peptides and ActivitiesDermatology and Skin Diseases
Cited by 1,960
- Verified
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 1,544
- Verified
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood
Iron Metabolism and DisordersErythropoietin and Anemia Treatment
Cited by 1,417
- Verified
Hepcidin and iron homeostasis
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 1,282
- Verified
Anemia of inflammation
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood
Iron Metabolism and DisordersErythropoietin and Anemia Treatment
Cited by 1,219
- Verified
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics
Iron Metabolism and DisordersHemoglobinopathies and Related Disorders
Cited by 1,127
- Verified
Systemic Iron Homeostasis
Ganz, T. (2013) · Physiological Reviews
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 1,122
- Verified
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics
Iron Metabolism and DisordersNeurological diseases and metabolism
Cited by 974
- Verified
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 962
- Verified
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine
Iron Metabolism and DisordersHemoglobinopathies and Related Disorders
Cited by 854
- Verified
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 843
- Verified
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 756
- Verified
Immunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood
Iron Metabolism and DisordersNeurological diseases and metabolism
Cited by 688
- Verified
Ironing out Ferroportin
Drakesmith, H., Nemeth, E., & Ganz, T. (2015) · Cell Metabolism
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 638
- Verified
The Role of Hepcidin in Iron Metabolism
Nemeth, E., & Ganz, T. (2009) · Acta Haematologica
Iron Metabolism and DisordersNeurological diseases and metabolism
Cited by 607
- Verified
Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response
Liuzzi, J. P., Lichten, L. A., Rivera, S., Blanchard, R. K., Aydemir, T. B., Knutson, M. D., Ganz, T., & Cousins, R. J. (2005) · Proceedings of the National Academy of Sciences
Trace Elements in HealthIron Metabolism and Disorders
Cited by 594
- Verified
Anemia of Inflammation
Ganz, T. (2019) · New England Journal of Medicine
Iron Metabolism and DisordersErythropoietin and Anemia Treatment
Cited by 589
- Verified
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Nemeth, E., & Ganz, T. (2021) · International Journal of Molecular Sciences
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 540
- Verified
Suppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood
Iron Metabolism and DisordersErythropoietin and Anemia Treatment
Cited by 472
- Verified
Hepcidin and disorders of iron metabolism
Ganz, T., & Nemeth, E. (2011) · Annual Review of Medicine
Iron Metabolism and DisordersFerroptosis and cancer prognosis
Cited by 466
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free